NVO NOVO NORDISK A S
NYSEHealth carePharmaceutical PreparationsBagsvaerd Denmark, DenmarkFY ends December 31
This company has no annual 10-K financial data in SEC EDGAR's XBRL facts (for example, foreign issuers that file Form 20-F, funds, or very small filers). Its filings are listed below.
Overview
NOVO NORDISK A S (NVO) is listed on NYSE; the SEC classifies it under "Pharmaceutical Preparations".
- Fiscal years shown
- —
- Latest 10-K
- —
- Latest filing
- 6-KNov 3, 2026
Filing timeline
- 6-KNewReport of foreign issuer· Nov 3, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Oct 26, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Oct 19, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Oct 12, 2023(SEC EDGAR)
- 6-KReport of foreign issuer· Oct 5, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Oct 2, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 28, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 21, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 17, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 14, 2026(SEC EDGAR)
Peers (same SIC code)
| Ticker | Revenue (FY) | YoY | Net margin | ROE | F-Score | 5y revenue |
|---|---|---|---|---|---|---|
| JNJJOHNSON & JOHNSON | $94.2B | — | 28.5% | — | — | — |
| LLYELI LILLY & Co | $65.2B | — | 31.7% | — | — | — |
| MRKMerck & Co., Inc. | $65B | — | 28.1% | — | — | — |
| PFEPFIZER INC | $62.6B | down 1.65% | 12.4% | 8.9% | 6/9 | |
| ABBVAbbVie Inc. | $61.2B | — | 6.9% | — | — | — |
| ABTABBOTT LABORATORIES | $44.3B | up 5.67% | 14.7% | 13.1% | 6/9 | |
| NVONOVO NORDISK A S (This company) | — | — | — | — | — | — |
| NVSNOVARTIS AG | — | — | — | — | — | — |
| AZNASTRAZENECA PLC | — | — | — | — | — | — |
| Peer median | $63.8B | up 2.01% | 21.4% | 11.0% | 6/9 | — |
Companies with the same 4-digit SIC code, ordered by latest revenue. The median excludes this company. — = not reported or not computable.
Frequently asked questions
What does NOVO NORDISK A S do?
The SEC classifies NOVO NORDISK A S under Standard Industrial Classification (SIC) code 2834, "Pharmaceutical Preparations". It is headquartered in Bagsvaerd Denmark, Denmark.
Where is NOVO NORDISK A S listed?
According to the SEC, NOVO NORDISK A S's ticker NVO is listed on NYSE. The SEC also lists the ticker NONOF for the company.
When does NOVO NORDISK A S's fiscal year end?
According to the SEC, NOVO NORDISK A S's fiscal year ends on December 31.
Source: SEC EDGAR · Last updated:
Ver en españolNot investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.